Tag: Biohaven Pharmaceutical

Stock selection criterion

Investment management

Click the tags to see associated articles and topics

View Article Details

Biohaven Pharmaceutical (NYSE:BHVN) Receives “Buy” Rating from Piper Jaffray Companies

Added to Collection on: 2018-12-17 13:26:15

Tags for this article:

Pharmacy

Securities research

Pharmacology

Click the tags to see associated articles and topics

View Article Details

Biohaven Pharmaceutical (BHVN) Given a $63.00 Price Target at Oppenheimer

Added to Collection on: 2018-12-18 21:30:00

Tags for this article:

Health

Pharmacy

Pharmacology

Medicinal chemistry

Click the tags to see associated articles and topics

View Article Details

Biohaven Pharmaceutical (NYSE:BHVN) Upgraded by ValuEngine to Buy

Added to Collection on: 2019-02-13 19:53:41

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Biohaven Pharmaceutical's (BHVN) “Hold” Rating Reiterated at Barclays

Added to Collection on: 2019-03-15 22:15:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

The Biohaven Pharmaceutical (BHVN) Given a $65.00 Price Target at Piper Jaffray Companies

Added to Collection on: 2019-05-31 04:54:00

Tags for this article:

Alternative investment management companies

Click the tags to see associated articles and topics

View Article Details

Biohaven Pharmaceutical (NYSE:BHVN) Price Target Raised to $76.00 at Morgan Stanley

Added to Collection on: 2021-04-19 14:26:15

Tags for this article: